Navigation Links
DURECT Corporation Announces Third Quarter 2010 Financial Results
Date:11/3/2010

ECT a royalty on product sales.In the third quarter of 2010, we continued to enroll patients in our U.S. pivotal Phase III clinical study known as BESST (Bupivacaine Effectiveness and Safety in SABER Trial).  We expect to complete enrollment of BESST, comprising approximately 300 patients, in the first half of 2011.POSIDUR is our post-operative pain relief depot that utilizes our patented SABER technology to deliver bupivacaine to provide up to three days of pain relief after surgery. POSIDUR is licensed to Hospira for commercialization in the U.S. and Canada, and to Nycomed for commercialization in Europe and other defined countries. We have retained commercialization rights in Japan and all other countries not subject to the Nycomed and Hospira licenses.•

ELADUR (TRANSDUR™-Bupivacaine).  In October 2008, worldwide rights to this program were licensed to Alpharma, which was acquired by King Pharmaceuticals in December 2008.  In April 2010, King Pharmaceuticals initiated a Phase IIb trial evaluating the safety and efficacy of ELADUR in patients with chronic low back pain.  King expects to enroll approximately 260 patients in this study and we expect to receive top-line results from that study in the first half of 2011.  Assuming Pfizer completes its acquisition of King, Pfizer will assume the development and commercialization rights and obligations to ELADUR.ELADUR is our proprietary transdermal patch intended to deliver bupivacaine for a period of up to three days from each application.•

TRANSDUR-Sufentanil.  In February 2009, a successful end-of-Phase II meeting with the FDA was conducted for this program outlining a potential regulatory pathway for the Phase III program and NDA submission. During 2009, we transitioned the program back to our control.  We are in discussions with potential partners regarding licensing development and commercialization rights to this program to which we
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
2. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
3. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
4. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
5. DURECT to Present at the Jefferies Global Life Sciences Conference
6. DURECT to Present at the Rodman & Renshaw Global Healthcare Conference
7. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
8. DURECT to Present at the Barclays Capital Global Healthcare Conference
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
11. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Texas , Nov. 26, 2014 ... today announced the completion of previously announced concurrent ... million.  After fees and estimated offering expenses, Lexicon ... the transactions.  The transactions consisted of: ... common stock, pursuant to a registration statement that ...
(Date:11/26/2014)...  Over 100 million adults suffer from chronic pain ... daily. Chronic and acute pain dramatically impacts quality of ... fulfill the need for non-surgical, interventional solutions and medication ... On October 28th, a new pain management center opened ... community.  This new facility boasts cutting edge technologies ...
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3New Pain Management Center Opens in Cumberland, Md. 2
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... there are many medical precautions and procedures in place ... the handling and disposal of things tainted with menstrual ... me to design a simpler, more sanitary way to ... environment," said an inventor from Sonora, Calif. , He ...
(Date:11/27/2014)... Randy Dotinga HealthDay ... Some people,s brains seem pre-wired to acquire a second language, ... their mother tongue will likely gain a brain boost, the ... and integrated after learning," said study co-author Ping Li, co-director ... State University. But it,s even more interesting, Li said, that ...
(Date:11/27/2014)... In order to enable people to adapt to the germaphobic ... to avoid touching a toilet seat and/or lid while raising ... the patent-pending Toilet Tamer, a device that enables a user ... a more sanitary manner. It avoids direct contact with dirty ... good hygiene and peace of mind. The portable device is ...
(Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... behalf of individuals who were allegedly injured by the ... court, where a federal litigation is looking ahead to ... , According to a Scheduling Order issued earlier ... take place on December 16th at 10:00 a.m. Items ...
(Date:11/27/2014)... Washington, DC (PRWEB) November 27, 2014 “LAB.C” ... Report, which features the latest and coolest technology products available ... NewsWatch, conducted the product review and shared with ... cable for iOS and Android devices. , Consumers love portability ... LAB.C. Their Cable Case for the iPhone5 and 5S ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
... News) -- High blood pressure is associated with a steeper ... study finds. Major decreases in walking speed can affect ... problems; it may also predict who will develop dementia or ... of 643 seniors over 14 years. The participants, who were ...
... organized follow-up care for depression effectively and efficiently, according ... patients that the Journal of General Internal Medicine ... five months, compared to the half of the patients ... had three online care management contacts with a trained ...
... University of Rochester physicians and scientists that has helped ... now more widely available, thanks to approval by the ... the Rochester Nomogram, marks a leap forward for patients ... Refractive surgeon Scott MacRae, M.D., helped develop the formula ...
... Young adults are more likely to be heavy drinkers if they ... also had to cope with stressful life events, a new study ... women and 140 men in Germany who were asked about when ... the previous three years, what daily hassles they might have had ...
... Decisions about whether and how to diagnose children with ... treat them, are sometimes not clear-cut. When decisions lie ... value commitments can reach different but equally respectable conclusions. ... a special report. However, one of the report,s ...
... HealthDay Reporter , TUESDAY, March 15 (HealthDay News) -- ... cell phones while crossing the street, because new research ... than for college students. In laboratory simulations at ... to 81 and 18 undergraduates aged 18 to 26 ...
Cached Medicine News:Health News:High Blood Pressure Linked to Drop in Walking Speed, Study Finds 2Health News:Online messaging delivers follow-up care for depression 2Health News:Rochester technology to enhance eyesight approved by FDA 2Health News:Rochester technology to enhance eyesight approved by FDA 3Health News:Drinking Behavior May Be Tied to Early Alcohol Use 2Health News:Depolarizing the debates about pediatric mental health diagnosis and treatment 2Health News:Depolarizing the debates about pediatric mental health diagnosis and treatment 3Health News:Depolarizing the debates about pediatric mental health diagnosis and treatment 4Health News:Crossing Street While on Cell Phone Risky for Seniors 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: